AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3

AbbVie's Rinvoq is delivering blockbuster sales and driving growth for the drugmaker after its January loss of exclusivity for top-selling Humira. Now, Rinvoq is taking a step toward another potential label expansion.